- Home
- IMMX vs FTCI Comparison
IMMX vs FTCI Comparison
Compare IMMX & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- FTCI
- Stock Information
- Founded
- IMMX 2014
- FTCI 2017
- Country
- IMMX United States
- FTCI United States
- Employees
- IMMX N/A
- FTCI N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- FTCI Semiconductors
- Sector
- IMMX Health Care
- FTCI Technology
- Exchange
- IMMX Nasdaq
- FTCI Nasdaq
- Market Cap
- IMMX 82.6M
- FTCI 93.0M
- IPO Year
- IMMX 2021
- FTCI 2021
- Fundamental
- Price
- IMMX $3.05
- FTCI $8.80
- Analyst Decision
- IMMX Strong Buy
- FTCI Buy
- Analyst Count
- IMMX 1
- FTCI 3
- Target Price
- IMMX $8.00
- FTCI $4.67
- AVG Volume (30 Days)
- IMMX 453.7K
- FTCI 54.3K
- Earning Date
- IMMX 11-11-2025
- FTCI 11-11-2025
- Dividend Yield
- IMMX N/A
- FTCI N/A
- EPS Growth
- IMMX N/A
- FTCI N/A
- EPS
- IMMX N/A
- FTCI N/A
- Revenue
- IMMX N/A
- FTCI $64,134,000.00
- Revenue This Year
- IMMX N/A
- FTCI $90.77
- Revenue Next Year
- IMMX N/A
- FTCI $130.32
- P/E Ratio
- IMMX N/A
- FTCI N/A
- Revenue Growth
- IMMX N/A
- FTCI N/A
- 52 Week Low
- IMMX $1.34
- FTCI $2.13
- 52 Week High
- IMMX $3.20
- FTCI $9.50
- Technical
- Relative Strength Index (RSI)
- IMMX 77.89
- FTCI 62.19
- Support Level
- IMMX $2.31
- FTCI $8.37
- Resistance Level
- IMMX $2.82
- FTCI $9.50
- Average True Range (ATR)
- IMMX 0.25
- FTCI 0.55
- MACD
- IMMX 0.08
- FTCI 0.08
- Stochastic Oscillator
- IMMX 95.41
- FTCI 69.96
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.